69 results
CORRESP
GOSS
Gossamer Bio Inc
5 Feb 19
Correspondence with SEC
12:00am
effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
the Company may
S-1
EX-10.18
GOSS
Gossamer Bio Inc
21 Dec 18
IPO registration
4:39pm
.
2.1General. The JDC’s overall responsibility shall be to encourage and facilitate ongoing cooperation between the Parties with respect … will establish a joint development committee (the “JDC”) composed of no more than three (3) representatives of each Party. The JDC will have responsibility
8-K
EX-99.1
GOSS
Gossamer Bio Inc
14 Jun 21
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
4:22pm
for Genentech, Inc., and from 2002 to 2012, she was at Amgen Inc. in positions of increasing responsibility across legal and regulatory affairs functions
S-3ASR
GOSS
Gossamer Bio Inc
10 Apr 20
Automatic shelf registration
4:33pm
no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We will not make an offer to sell … , as is the case with securities held for the account of customers in bearer form or registered in “street name.” Those payments will be the responsibility
DRS
EX-10.14
GOSS
Gossamer Bio Inc
11 Oct 18
Draft registration statement
12:00am
(a)
Section 2.Development.
2.1General. The JDC’s overall responsibility shall be to encourage and facilitate ongoing cooperation between the Parties … responsibility for (i) reviewing and overseeing the overall progress of development and manufacturing activities under this Agreement with respect
S-3ASR
xfdfjd0 nzvvrps41d9
3 Mar 22
Automatic shelf registration
4:05pm
8-K
qtvhvpg
14 Jun 21
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
4:22pm
424B5
b756paaeyz94
18 May 20
Prospectus supplement for primary offering
4:11pm
424B5
01032 9fd5
19 May 20
Prospectus supplement for primary offering
5:08pm
DEF 14A
e8wb yaqxbrmj
30 Apr 19
Definitive proxy
4:04pm
PRE 14A
z5hq4dvtbcdbtx mv
17 Apr 23
Preliminary proxy
4:01pm
424B5
00gwfmnz
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
9li3lfg0zdd5ku1
18 May 20
Prospectus supplement for primary offering
4:16pm
S-1
EX-10.17
z6o7vinw3ji acrwpmh
21 Dec 18
IPO registration
4:39pm